The global Implantable Cardioverter Defibrillator (ICD) market size is expected to reach USD 8.81 Billion at a steady CAGR of 2.7% in 2028, according to latest analysis by Emergen Research. The market for implantable cardioverter defibrillators is growing due to an increase in prevalence of cardiac diseases. Surge in risk factors such as obesity and rise in sedentary lifestyle are other key factors driving the growth of ICD market.

Global Implantable Cardioverter Defibrillator Market Research Report and Forecast to 2028 is an investigative report providing an extensive study of the global Implantable Cardioverter Defibrillator market with regards to market size, market share, current and emerging trends, and latest technological developments. The report also sheds light on the competitive landscape of the Implantable Cardioverter Defibrillator market on the global and regional scale, along with a thorough forecast estimation to 2028.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/732

Implantable cardioverter defibrillator is a small battery powered device placed on an individual’s chest to monitor heart rhythm and detect abnormal heartbeats. The device can deliver electric shocks via wires to fix heart arrhythmias. Rising prevalence of cardiovascular diseases and increase in global geriatric population are factors fueling growth of the market to a significant extent. Emergence of MRI-compatible implantable cardioverter defibrillator is also expected to contribute to market revenue growth. Upsurge in adoption of subcutaneous ICDs due to various benefits is also expected to fuel market revenue growth.

Top competitors of the Implantable Cardioverter Defibrillator Market profiled in the report include:

Boston Scientific Corporation, Abbott Laboratories, Biotronik, Medtronic PLC, LivaNova PLC, MicroPort, Sorin Group, Koninklijke Philips N.V., Fukuda Denshi Co. Ltd., and Physio-Control, Inc. Others

Hospitals clinics segment accounted for largest revenue share in 2020 as these settings are the major point of care for treatment of heart diseases, including cardiac arrest. Rising incidence of deaths due to cardiovascular diseases is driving revenue growth of this segment as hospitals have advanced medical infrastructure and treatment facilities.

Implantable cardioverter defibrillator market revenue in Asia Pacific is expected to continue to register a rapid revenue growth rate during the forecast period due to rapid economic growth in countries such as India and China. High adoption of implantable cardioverter defibrillators due to emergence of a number of more advanced hospitals in developing countries is expected to contribute to market revenue growth.

Request a discount on the report @ https://www.emergenresearch.com/request-discount/732

Product Type Outlook (Revenue, USD Billion; 2018–2028)

• Transvenous ICD
1. Single Chamber ICD
2. Dual Chamber ICD
3. CRT-D (cardiac resynchronization therapy-defibrillator)
• Subcutaneous ICD

End-use Channel Outlook (Revenue, USD Billion; 2018–2028)

• Hospitals Clinics
• Ambulatory Surgery Centers
• Others

Regional Analysis of the Implantable Cardioverter Defibrillator Market:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/implantable-cardioverter-defibrillator-market

Market Overview:

The research report on the Implantable Cardioverter Defibrillator market is formulated through extensive primary and secondary research along with qualitative and quantitative analysis of vital aspects of the market. The insightful data is further validated and verified by the industry professionals. The report strives to offer deeper insights into the overall market scenario of the Implantable Cardioverter Defibrillator business sphere.

Key Objectives of the Report:

• Analysis and estimation of the Implantable Cardioverter Defibrillator market size and share for the projected period of 2020-2028
• Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
• Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Implantable Cardioverter Defibrillator market
• Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
• Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Request customization of the report @ https://www.emergenresearch.com/request-discount/732

Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Browse Similar Report:

Orthopedic Biomaterial Market: https://marketographics.com/orthopedic-biomaterial-market/

Slide Stainers Market: https://marketographics.com/slide-stainers-market/

Liquid Biopsy Market: https://marketographics.com/liquid-biopsy-market/

Prefilled Syringes Market: https://marketographics.com/prefilled-syringes-market/

Temperature Monitoring Systems Market: https://marketographics.com/temperature-monitoring-systems-market/

Soil Testing Equipment Market: https://marketographics.com/soil-testing-equipment-market/